DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
ICER – Institute for Clinical and Economic Review.
Emicizumab for hemophilia A with inhibitors: effectiveness and value.
Final evidence report. April 16, 2018. Available at:
https://icer-review.org/wp-content/uploads/2017/08/ICER_Hemophilia_Final_Evidence_Report_041618.pdf . Accessed April 16, 2019
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.